Lauren Biscaldi is the Managing Editor of Drug Topics.
FDA Expands Novavax EUA for Use in Adolescents Aged 12 to 17
The vaccine was previously authorized under an EUA for adults aged 18 and older.
At a Glance: Interim COVID-19 Immunization Schedule
The latest guidance for when to administer the COVID-19 vaccine to patients aged 6 months and older.
Become the Pharmacy of the Future With Technology Solutions
Technology can help manage every aspect of the pharmacy.
Q&A: Improving E-Prescribing With FDB Vela
Drug Topics® sat down with Bob Katter to discuss what FDB Vela brings to the table to improve the prescribing process, particularly with specialty medications.
Partnering for Success: How the GNP Business Coach-Pharmacy Partnership Helped Propel One Independent Pharmacy to Success
The relationship between Bright Plaza Pharmacy and their AmerisourceBergen business coach has proved invaluable during the pandemic and beyond.
WHO Declares Monkeypox a Global Health Emergency
The decision comes following reports of 16,000 cases across 75 countries and territories around the world.
Podcast: What You Missed at ThoughtSpot 2022 Day 1
The Drug Topics® team is on the ground at ThoughtSpot 2022. Here's what you missed on Day 1.
Thinking Back and Looking Forward, Good Neighbor Pharmacy Is Ready for the Next 40 Years
After 40 years of experience, Good Neighbor Pharmacy is ready to tackle whatever challenges lie ahead for independent pharmacies.
Breaking: FDA Issues EUA for Novavax COVID-19 Vaccine, Adjuvanted
Adults aged 18 and older are eligible to receive the vaccine.
First, Only Zonisamide Oral Suspension for Treatment of Partial Seizures Approved by FDA
The approval represents an adjunctive therapy option for adults and pediatric patients older than age 16.
Specialty Drug Pipeline Updates for 2022
The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.
Prescription to OTC Switches A Boon for Pharmacy Front End
Medications that switch from prescription-only to OTC can be stocked in the pharmacy’s front end.
Breaking: Pharmacists Authorized by FDA to Prescribe Paxlovid, With Limitations
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
Daily Harvest Issues Widespread Recall as Reports of Gastrointestinal Emergencies Surface
Pharmacists who encounter patients with severe gastrointestinal complains may want to stay abreast of ongoing issues with the meal delivery service.
World Health Network Declares Monkeypox Outbreak a Pandemic
The decision came as the World Health Organization prepared to meet on June 23.
Clinical Pharmacists Value During Transition of Care Services Evaluated
During this period, pharmacists can optimize medications, monitor adherence, and improve access.
Does Pharmacist Involvement Impact Rate of Infliximab Biosimilar Switching?
Infliximab biosimilars have been available since 2016.
Hospital-Based Outpatient Pharmacy Successfully Completes RZV Vaccination Pilot Program
The program administered 60 vaccines to patients referred by their primary care physicians.
Immunology Pipeline Includes New Approvals, Expanded Indications for Dermatology, Reparatory, and GI
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
COVID-19 Vaccine Acceptance Rates Still Vary Among Pharmacy Professionals
A majority of survey respondents were willing to receive a COVID-19 vaccine.
Two Hemophilia Drugs Lead Hematology Pipeline Update
Both drugs address an unmet need for patients with hemophilia A or B.
Integrated Health System Pharmacy Models Associated With Medication Adherence, Fewer Side Effects
Patient reported outcomes for were positive for those who filled medications at an integrated health system specialty pharmacy.
Craving Connection, Pharmacists Celebrate a Return to In-Person Events
The move back to live meetings has energized AAP’s staff and members.
FDA Approves Baricitinib Oral Tablets as First Systemic Alopecia Areata Treatment
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Next-In-Class Treatments Lead Oncology Drug Pipeline Update
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
Financial Toxicity, Administrative Sludge Among Roadblocks for Specialty Oncology Care
Strict utilization management policies have led some patients to make decisions like skipping medication doses.
Total Pharmacy Solutions Summit: A Day of Education for Independent Pharmacists
Thoughts leaders from across the community and independent pharmacy spaces came together for a day of education and insight.
FDA Committee Recommends Novavax COVID-19 Vaccine for Authorization
If authorized, it will be the fourth COVID-19 vaccine available in the Untied States.
Examining the Professional Landscape for Pharmacy Techs
The scope of practice for pharmacy techs has changed in recent years, allowing for greater responsibilities, and the current labor shortage poses some challenges.
Breaking: FDA Authorizes Pfizer-BioNTech Booster Shot for Children Ages 5 to 11
Children may receive a single booster shot at least 5 months after completing their initial Pfizer-BioNTech 2-dose series.